Skip to content
lifestyle.xbode.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
SK Life Science , Inc.
SK Life Science, Inc. Announces FDA Acceptance for Review of New Drug Application for Cenobamate Oral Suspension
June 15, 2026
SK Life Science, Inc. Launches Epilepsy Connect to Empower Advanced Practice Providers in Epilepsy Care
April 16, 2026
SK Life Science, Inc. to Present New Data and Epilepsy Insights at the 2026 American Academy of Neurology Annual Meeting
April 6, 2026